After consulting the literature, we found that in psoriasis and cancer diseases, the IL-17 signaling pathway can cause the production of pro-inflammatory factors such as S100a8 and S100a9, thereby promoting the generation of inflammation and the metastasis of cancer cells [26,27]. The gene discussed is IL17A; the disease is cancer.